Annual EBITDA
-$8.31 M
+$7.82 M+48.49%
31 December 2023
Summary:
Synaptogenix annual earnings before interest, taxes, depreciation & amortization is currently -$8.31 million, with the most recent change of +$7.82 million (+48.49%) on 31 December 2023. During the last 3 years, it has risen by +$2.84 million (+25.50%). SNPX annual EBITDA is now at all-time high.SNPX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.36 M
+$221.60 K+14.03%
30 September 2024
Summary:
Synaptogenix quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.36 million, with the most recent change of +$221.60 thousand (+14.03%) on 30 September 2024. Over the past year, it has increased by +$70.10 thousand (+4.91%). SNPX quarterly EBITDA is now at all-time high.SNPX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$6.76 M
+$70.10 K+1.03%
30 September 2024
Summary:
Synaptogenix TTM earnings before interest, taxes, depreciation & amortization is currently -$6.76 million, with the most recent change of +$70.10 thousand (+1.03%) on 30 September 2024. Over the past year, it has increased by +$5.30 million (+43.97%). SNPX TTM EBITDA is now -72.65% below its all-time high of -$3.91 million, reached on 30 September 2019.SNPX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SNPX EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +48.5% | +4.9% | +44.0% |
3 y3 years | +25.5% | +53.6% | +40.4% |
5 y5 years | - | +65.3% | -72.7% |
SNPX EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +48.5% | at high | +76.9% | at high | +58.1% |
5 y | 5 years | at high | +48.5% | at high | +76.9% | -72.7% | +58.1% |
alltime | all time | at high | +48.5% | at high | +76.9% | -72.7% | +58.1% |
Synaptogenix EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$1.36 M(-14.0%) | -$6.76 M(-1.0%) |
June 2024 | - | -$1.58 M(-6.5%) | -$6.83 M(-3.5%) |
Mar 2024 | - | -$1.69 M(-20.7%) | -$7.08 M(-14.8%) |
Dec 2023 | -$8.31 M(-48.5%) | -$2.13 M(+49.2%) | -$8.31 M(-31.1%) |
Sept 2023 | - | -$1.43 M(-21.9%) | -$12.06 M(-12.6%) |
June 2023 | - | -$1.83 M(-37.4%) | -$13.80 M(-12.5%) |
Mar 2023 | - | -$2.92 M(-50.4%) | -$15.77 M(-2.2%) |
Dec 2022 | -$16.13 M | -$5.89 M(+86.0%) | -$16.13 M(+11.4%) |
Sept 2022 | - | -$3.17 M(-16.6%) | -$14.48 M(+1.7%) |
June 2022 | - | -$3.79 M(+15.7%) | -$14.24 M(+11.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$3.28 M(-22.6%) | -$12.74 M(+1.0%) |
Dec 2021 | -$12.61 M(+13.1%) | -$4.24 M(+44.7%) | -$12.61 M(+11.2%) |
Sept 2021 | - | -$2.93 M(+27.6%) | -$11.34 M(+3.2%) |
June 2021 | - | -$2.29 M(-27.3%) | -$10.99 M(-6.1%) |
Mar 2021 | - | -$3.15 M(+6.4%) | -$11.70 M(+4.9%) |
Dec 2020 | -$11.15 M(-28.1%) | -$2.96 M(+15.1%) | -$11.15 M(+2.5%) |
Sept 2020 | - | -$2.58 M(-14.3%) | -$10.88 M(-11.0%) |
June 2020 | - | -$3.01 M(+15.3%) | -$12.22 M(+32.6%) |
Mar 2020 | - | -$2.61 M(-3.1%) | -$9.21 M(+39.5%) |
Dec 2019 | -$15.51 M | -$2.69 M(-31.3%) | -$6.60 M(+68.7%) |
Sept 2019 | - | -$3.91 M | -$3.91 M |
FAQ
- What is Synaptogenix annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Synaptogenix?
- What is Synaptogenix annual EBITDA year-on-year change?
- What is Synaptogenix quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Synaptogenix?
- What is Synaptogenix quarterly EBITDA year-on-year change?
- What is Synaptogenix TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Synaptogenix?
- What is Synaptogenix TTM EBITDA year-on-year change?
What is Synaptogenix annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of SNPX is -$8.31 M
What is the all time high annual EBITDA for Synaptogenix?
Synaptogenix all-time high annual earnings before interest, taxes, depreciation & amortization is -$8.31 M
What is Synaptogenix annual EBITDA year-on-year change?
Over the past year, SNPX annual earnings before interest, taxes, depreciation & amortization has changed by +$7.82 M (+48.49%)
What is Synaptogenix quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of SNPX is -$1.36 M
What is the all time high quarterly EBITDA for Synaptogenix?
Synaptogenix all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.36 M
What is Synaptogenix quarterly EBITDA year-on-year change?
Over the past year, SNPX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$70.10 K (+4.91%)
What is Synaptogenix TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of SNPX is -$6.76 M
What is the all time high TTM EBITDA for Synaptogenix?
Synaptogenix all-time high TTM earnings before interest, taxes, depreciation & amortization is -$3.91 M
What is Synaptogenix TTM EBITDA year-on-year change?
Over the past year, SNPX TTM earnings before interest, taxes, depreciation & amortization has changed by +$5.30 M (+43.97%)